Frame Cancer Therapeutics Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Frame Cancer Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
Frame Cancer Therapeutics's estimated revenue per employee is $201,000

Name	Title	Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Lygature	$13.9M	69	-1%	N/A	N/A
#2 Lonza Netherlan...	$43.8M	218	-13%	N/A	N/A
#3 ACE Pharmaceuti...	$51.9M	258	4%	N/A	N/A
#4 Dopharma B.V.	$32.2M	160	0%	N/A	N/A
#5 Spepharm Holdin...	$237.8M	1183	-1%	N/A	N/A
#6 Frame Cancer Th...	$3.8M	19	46%	N/A	N/A
#7 Norgine	$237.8M	1183	-1%	N/A	N/A
#8 Sanquin Plasma	$20.1M	100	-31%	N/A	N/A
#9 Prothya Biosolu...	$75M	373	-8%	N/A	N/A
#10 NIA - Verenigin...	$2M	10	25%	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$3.8M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Achilles Therapeutics, Advaxis Inc, Frame Cancer Therapeutics, Genocea Biosciences Inc, Gradalis Inc, Gritstone Inc, Immunicum AB, Medigene,...

Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours. HT-KIT inhibits tumor growth...

Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours. HT-KIT inhibits tumor growth...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Aeves Groep	$2.5M	19	138%	N/A
#2 European Direct...	$2.9M	19	-5%	N/A
#3 Closing the Loo...	$2.4M	19	6%	N/A
#4 Azavista	$1.7M	19	-5%	N/A
#5 Vive	$2.4M	19	0%	N/A